June 25 - 26, 2020

2nd Annual MarketsandMarkets Cell-Gene therapy Bioprocessing Online Conference( Time Zone - EASTERN STANDARD TIME (EST)

30+
Speaker
10+
Networking Hours
150+
Attendees

Virtual engaging model to exact solutions for robust manufacturing and bioprocessing challenges

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In our conference of 2017, we assessed the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.

There are still factors like manufacturing maze, investment, logistics and regulatory challenges that prevent the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 2nd Annual MarketsandMarkets Cell & Gene Therapy Bioprocessing Online Conference. Learn from the leading experts of the industry about strategies, technologies, and innovations in the area of bioprocessing of cell-gene therapies.

Due to growing concerns about COVID-19, the event is going fully virtual this year. We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 25th & 26th June 2020. Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT
Key Highlights
  • Bioprocessing of 3D cell culture
  • CHO cell lines bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • Optimization of cell-gene therapies
  • Supply chain and reimbursement issues
  • Regulatory guidelines cell and gene-based medicines
Why Attend?
  • Learn the latest advancement and opportunities in the area of manufacturing of cell-gene therapies
  • Gain insights in the area of the automated and most effective manufacturing processes
  • Network with the key professionals addressing the strategies of supply chain and regulatory hurdles
Who Should attend?

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:

Engineers/ Scientists/ Researchers/ Project leaders in:

  • Bioprocess development
  • Process development
  • GMP/Manufacturing
  • Cellular Therapy
  • Gene Therapy
  • Quality Control
  • Cell Engineering
  • Regulatory affairs
CONFERENCE AGENDA
CONFERENCE SPEAKERS
Advisors
Tiffany Rau

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals
Shon Green

Shon Green

Director, Clinical Translation
Altius Institute for Biomedical Sciences

Shon Green

Director, Clinical Translation
Altius Institute for Biomedical Sciences
Scott Burger

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC
Geoffrey Hodge

Geoffrey Hodge

Chief Technical Officer
Unum Therapeutics

Geoffrey Hodge

Chief Technical Officer
Unum Therapeutics
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Board Member
MarketsandMarkets

Shailendra Singh (Shelly)

Board Member
MarketsandMarkets
Tiffany Rau

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-
Biotechnology, Biopharmaceuticals
Scott Burger

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC

Scott Burger

Principal
Advanced Cell & Gene Therapy LLC
Jan Joseph Melenhorst

Jan Joseph Melenhorst

Adjunct Associate Professor
Upenn

Jan Joseph Melenhorst

Adjunct Associate Professor
Upenn
John Rossi

John Rossi

Director, Translational Sciences
Kite Pharma

John Rossi

Director, Translational Sciences
Kite Pharma
Devyn Smith

Devyn Smith

Chief Operating Officer
Sigilon Therapeutics

Devyn Smith

Chief Operating Officer
Sigilon Therapeutics
Hemant Dhamne

Hemant Dhamne

Head of Vector and CAR-T Cell Processing
Immuneel Therapeutics Pvt Ltd

Hemant Dhamne

Head of Vector and CAR-T Cell Processing
Immuneel Therapeutics Pvt Ltd
Don Healey

Don Healey

SVP Operations and Site Head
KBI Pharma

Don Healey

SVP Operations and Site Head
KBI Pharma
SPONSORS
Leading Partner
example-image

SCIEX

Sponsors & Exhibitors
example-image

GenScript

example-image

Eppendorf

example-image

OXGENE

example-image

Proteintech

Speaking Partner
example-image

Tosoh Bioscience

example-image

CPC

Primary Partner
example-image

SGS

PAST EVENT GALLERY